Evidence map›Paper›PMID 33466521›Full record

ArticlePathogens (Basel, Switzerland)2021

Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing

Wen-Chi Chen, Chih-Hsin Hung, Yao-Shen Chen, Jin-Shiung Cheng, Susan Shin-Jung Lee, Fan-Chen Tseng, Ming-Fang Cheng, Jiun-Ling Wang

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Microorganisms · 2022
    Article
  4. Molecular Epidemiology ofAntibiotics (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Wen-Chi ChenDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital and School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.
Chih-Hsin HungDepartment of Chemical Engineering and Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung 840, Taiwan.
Yao-Shen ChenDivision of Infectious Disease, Department of Internal Medicine, Kaohsiung Veterans General Hospital and School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.
Jin-Shiung ChengDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital and School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.
Susan Shin-Jung LeeDivision of Infectious Disease, Department of Internal Medicine, Kaohsiung Veterans General Hospital and School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.ORCID 0000-0001-5162-2414
Fan-Chen TsengGraduate Institute of Basic Medical Science, China Medical University and Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei 112, Taiwan.
Ming-Fang ChengDepartment of Chemical Engineering and Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung 840, Taiwan.
Jiun-Ling WangDepartment of Internal Medicine, National Cheng Kung University Hospital, Tainan 704, Taiwan.ORCID 0000-0002-9465-8692
National Yang Ming Chiao Tung University · TWChina Medical University · TWI-Shou University · TWNational Cheng Kung University Hospital · TW

Funding

Kaohsiung Veterans General Hospital VGHKS 104-025Ministry of Science and Technology, Taiwan MOST 107-2314-B-075B-081-004
6 · The paper itself

Abstract

backgroundThis study aimed to investigate the frequency of sequence type (ST) 131 strains and outcome of cirrhotic patients with bloodstream infections (BSIs) caused by extended-spectrum beta-lactamase-producing

methodsThe incidence of ST 131 strains, hospital stay, and 30-day re-admission/mortality were compared between 51 ESBLEC and 51 NESBLEC bacteremic patients with cirrhosis.

resultsST 131 strains were found in 35.3% of the ESBLEC group and 0% of the NESBLEC group (

conclusionIn patients with cirrhosis, the ESBLEC BSIs group had a higher frequency of ST 131 strains and longer hospital stay than the NESBLEC BSIs group with similar 30-day re-admission/mortality. ST 131 strains were associated with 30-day re-admission.

Indexed as

bacteremia cirrhosisEscherichia coliextended-spectrum beta-lactamasesequence type 131

Identifiers

PMID33466521
PMCPMC7824895
OpenAlexW3120512328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.